Accelerate Drug Development
Tapping into a flourishing database, Hekma connects sites available for clinical trials to pharma
instantly
The Top 10 research institutions in the US alone support more than 22% of the global studies,
leaving 100 of thousands of sites and millions of patients untapped. Hekma bridges that gap by
partnering pharma with new sites, expanding their reach to a more diverse patient base and
accelerating drug development
By expanding the scope of potential patients that pharma has access to, Hekma provides a vital
solution, curtailing trial duration and cost over time
Connecting patient to pharma at wire speed
Improve future clinical trial design
Access to new Sites
Shortened time, Cost reduced
Early collaboration with Sites
Hekma Open Square​
Our Open Square is a marketplace for hospitals and pharma to connect privately and securely, enabling patients to participate in clinical trials globally. This marketplace is a groundbreaking platform designed to connect under-represented and diverse patients with eager pharma looking to conduct patient trials
Scan & Find
Hekma secure AI platform deployed @ Hospital
Engage
Patient2Trials and Trial2Patients, Hekma provides qualified patient profiles
Accelerate
Pharma gets intelligent insight about patients and new clinical sites
Interested in learning how Hekma can help
